Cargando…

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains

[Image: see text] Small-molecule inhibitors that target bromodomains outside of the bromodomain and extra-terminal (BET) sub-family are lacking. Here, we describe highly potent and selective ligands for the bromodomain module of the human lysine acetyl transferase CBP/p300, developed from a series o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hay, Duncan A., Fedorov, Oleg, Martin, Sarah, Singleton, Dean C., Tallant, Cynthia, Wells, Christopher, Picaud, Sarah, Philpott, Martin, Monteiro, Octovia P., Rogers, Catherine M., Conway, Stuart J., Rooney, Timothy P. C., Tumber, Anthony, Yapp, Clarence, Filippakopoulos, Panagis, Bunnage, Mark E., Müller, Susanne, Knapp, Stefan, Schofield, Christopher J., Brennan, Paul E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183655/ https://www.ncbi.nlm.nih.gov/pubmed/24946055 http://dx.doi.org/10.1021/ja412434f

Ejemplares similares

[1,2,4]Triazolo[4,3-a]phthalazines: Inhibitors of Diverse Bromodomains
por: Fedorov, Oleg, et al.
Publicado: (2013)

Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance
por: Fedorov, Oleg, et al.
Publicado: (2015)

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family
por: Filippakopoulos, Panagis, et al.
Publicado: (2012)

3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands
por: Hewings, David S., et al.
Publicado: (2011)

Stimulation of Hepatic Apolipoprotein A-I Production by Novel Thieno-Triazolodiazepines: Roles of the Classical Benzodiazepine Receptor, PAF Receptor, and Bromodomain Binding
por: Kempen, Herman J, et al.
Publicado: (2013)

A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation–π Interaction**
por: Rooney, Timothy P C, et al.
Publicado: (2014)

Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands
por: Hewings, David S., et al.
Publicado: (2013)

Bromodomains as therapeutic targets
por: Muller, Susanne, et al.
Publicado: (2011)

CBP/p300 Bromodomains Regulate Amyloid-like Protein Aggregation upon Aberrant Lysine Acetylation
por: Olzscha, Heidi, et al.
Publicado: (2017)

Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia
por: Picaud, Sarah, et al.
Publicado: (2016)

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
por: Ciceri, Pietro, et al.
Publicado: (2014)

Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain
por: Chaikuad, Apirat, et al.
Publicado: (2016)

Molecular Basis of Histone Tail Recognition by Human TIP5 PHD Finger and Bromodomain of the Chromatin Remodeling Complex NoRC
por: Tallant, Cynthia, et al.
Publicado: (2015)

Identification and Development of 2,3-Dihydropyrrolo[1,2-a]quinazolin-5(1H)-one Inhibitors Targeting Bromodomains within the Switch/Sucrose Nonfermenting Complex
por: Sutherell, Charlotte L., et al.
Publicado: (2016)

Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit
por: Fish, Paul V., et al.
Publicado: (2012)

Selective inhibition of BET bromodomains
por: Filippakopoulos, Panagis, et al.
Publicado: (2010)

Structure Enabled Design of BAZ2-ICR, A Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B
por: Drouin, Ludovic, et al.
Publicado: (2015)

Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
por: Filippakopoulos, Panagis, et al.
Publicado: (2012)

Discovery of Benzo[d]imidazole‐6‐sulfonamides as Bromodomain and Extra‐Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain
por: Cipriano, Alessandra, et al.
Publicado: (2022)

SPOTing Acetyl-Lysine Dependent Interactions
por: Picaud, Sarah, et al.
Publicado: (2015)

Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF
por: Bennett, James, et al.
Publicado: (2015)

9H-Purine Scaffold Reveals Induced-Fit Pocket Plasticity of the BRD9 Bromodomain
por: Picaud, Sarah, et al.
Publicado: (2015)

Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching
por: Philpott, Martin, et al.
Publicado: (2014)

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor**
por: Clark, Peter G K, et al.
Publicado: (2015)

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor
por: Clark, Peter G. K., et al.
Publicado: (2015)

CBP/p300 Bromodomain Inhibitor–I–CBP112 Declines Transcription of the Key ABC Transporters and Sensitizes Cancer Cells to Chemotherapy Drugs
por: Strachowska, Magdalena, et al.
Publicado: (2021)

Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
por: Cribbs, Adam P., et al.
Publicado: (2021)

Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening
por: Vidler, Lewis R., et al.
Publicado: (2013)

Selective Targeting of Bromodomains of the Bromodomain-PHD Fingers Family Impairs Osteoclast Differentiation
por: Meier, Julia C., et al.
Publicado: (2017)

An Activity‐Based Probe Targeting Non‐Catalytic, Highly Conserved Amino Acid Residues within Bromodomains
por: D'Ascenzio, Melissa, et al.
Publicado: (2018)

Distinct modulation of IFNγ-induced transcription by BET bromodomain and catalytic P300/CBP inhibition in breast cancer
por: Hogg, Simon J., et al.
Publicado: (2022)

Targeting Low-Druggability Bromodomains: Fragment Based Screening and Inhibitor Design against the BAZ2B Bromodomain
por: Ferguson, Fleur M., et al.
Publicado: (2013)

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
por: Conery, Andrew R, et al.
Publicado: (2016)

A chemical toolbox for the study of bromodomains and epigenetic signaling
por: Wu, Qin, et al.
Publicado: (2019)

Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
por: Conery, Andrew R, et al.
Publicado: (2016)

Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma
por: Zhang, Xin, et al.
Publicado: (2020)

Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
por: Chen, Qingjuan, et al.
Publicado: (2022)

Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis
por: Myrianthopoulos, Vassilios, et al.
Publicado: (2016)

Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains
por: Lambert, Jean-Philippe, et al.
Publicado: (2019)

Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP Bromodomain
por: Brand, Michael, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hbuvkgqja8j066k64bg09l75d9